Lactobacillus rhamnosus attenuates Thai chili extracts induced gut inflammation and dysbiosis despite capsaicin bactericidal effect against the probiotics, a possible toxicity of high dose capsaicin
- 2021-12-23
- PLOS ONE 16(12)
- Wimonrat Panpetch
- Peerapat Visitchanakun
- Wilasinee Saisorn
- A. Sawatpanich
- Piraya Chatthanathon
- N. Somboonna
- S. Tumwasorn
- A. Leelahavanichkul
- PubMed: 34941893
- DOI: 10.1371/journal.pone.0261189
Abstract
Because of a possible impact of capsaicin in the high concentrations on enterocyte injury (cytotoxicity) and bactericidal activity on probiotics, Lactobacillus rhamnosus L34 (L34) and Lactobacillus rhamnosus GG (LGG), the probiotics derived from Thai and Caucasian population, respectively, were tested in the chili-extract administered C57BL/6 mice and in vitro experiments. In comparison with placebo, 2 weeks administration of the extract from Thai chili in mice caused loose feces and induced intestinal permeability defect as indicated by FITC-dextran assay and the reduction in tight junction molecules (occludin and zona occludens-1) using fluorescent staining and gene expression by quantitative real-time polymerase chain reaction (qRT-PCR). Additionally, the chili extracts also induced the translocation of gut pathogen molecules; lipopolysaccharide (LPS) and (1→3)-β-d-glucan (BG) and fecal dysbiosis (microbiome analysis), including reduced Firmicutes, increased Bacteroides, and enhanced total Gram-negative bacteria in feces. Both L34 and LGG attenuated gut barrier defect (FITC-dextran, the fluorescent staining and gene expression of tight junction molecules) but not improved fecal consistency. Additionally, high concentrations of capsaicin (0.02-2 mM) damage enterocytes (Caco-2 and HT-29) as indicated by cell viability test, supernatant cytokine (IL-8), transepithelial electrical resistance (TEER) and transepithelial FITC-dextran (4.4 kDa) but were attenuated by Lactobacillus condition media (LCM) from both probiotic-strains. The 24 h incubation with 2 mM capsaicin (but not the lower concentrations) reduced the abundance of LGG (but not L34) implying a higher capsaicin tolerance of L34. However, Lactobacillus rhamnosus fecal abundance, using qRT-PCR, of L34 or LGG after 3, 7, and 20 days of the administration in the Thai healthy volunteers demonstrated the similarity between both strains. In conclusion, high dose chili extracts impaired gut permeability and induced gut dysbiosis but were attenuated by probiotics. Despite a better capsaicin tolerance of L34 compared with LGG in vitro, L34 abundance in feces was not different to LGG in the healthy volunteers. More studies on probiotics with a higher intake of chili in human are interesting.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lacticaseibacillus rhamnosus | Reduced Enterocyte Damage | Beneficial | Moderate |
Lacticaseibacillus rhamnosus | Reduced Gut Barrier Defect | Beneficial | Moderate |
Lactobacillus rhamnosus | Reduced Enterocyte Damage | Beneficial | Moderate |
Lactobacillus rhamnosus GR-1 | Attenuated Gut Dysbiosis | Beneficial | Moderate |
Lactobacillus rhamnosus GR-1 | Reduced Enterocyte Damage | Beneficial | Moderate |
Lactobacillus rhamnosus GR-1 | Reduced Gut Barrier Defect | Beneficial | Moderate |
Lactobacillus rhamnosus GR-1 | Reduced Gut Permeability | Beneficial | Moderate |
Lactobacillus rhamnosus LCS-742 | Improved Capsaicin Tolerance | Beneficial | Small |
Lactobacillus rhamnosus LCS-742 | Reduced Dysbiosis | Beneficial | Moderate |
Lactobacillus rhamnosus LCS-742 | Reduced Enterocyte Damage | Beneficial | Moderate |
Lactobacillus rhamnosus LCS-742 | Reduced Gut Barrier Defect | Beneficial | Moderate |
Lactobacillus rhamnosus LR04 | Improved Gut Barrier Function | Beneficial | Moderate |
Lactobacillus rhamnosus LR04 | Reduced Enterocyte Injury from Capsaicin | Beneficial | Moderate |
Lactobacillus rhamnosus LR05 | Improved Gut Microbiota Balance | Beneficial | Moderate |
Lactobacillus rhamnosus LR05 | Improved Intestinal Barrier Function | Beneficial | Moderate |
Lactobacillus rhamnosus LR05 | Reduced Inflammation | Beneficial | Moderate |
Lactobacillus rhamnosus LR06 | Improved Barrier Integrity | Beneficial | Moderate |
Lactobacillus rhamnosus LR06 | Reduced Enterocyte Damage | Beneficial | Moderate |
Lactobacillus rhamnosus LR06 | Reduced Intestinal Permeability | Beneficial | Moderate |
Lactobacillus rhamnosus LRa05 | Reduced Enterocyte Damage | Beneficial | Moderate |
Lactobacillus rhamnosus LRa05 | Reduced Gut Barrier Defect | Beneficial | Moderate |
Lactobacillus rhamnosus lysate powder | No Change in Fecal Abundance of L34 or LGG | Neutral | Small |
Lactobacillus rhamnosus lysate powder | Reduced Enterocyte Damage | Beneficial | Moderate |
Lactobacillus rhamnosus lysate powder | Reduced Gut Barrier Defect | Beneficial | Moderate |
Lactobacillus rhamnosus MAK79L08R | Improved Capsaicin Tolerance | Beneficial | Small |
Lactobacillus rhamnosus MAK79L08R | Improved Gut Microbiota Balance | Beneficial | Moderate |
Lactobacillus rhamnosus MAK79L08R | Improved Intestinal Barrier Function | Beneficial | Moderate |
Lactobacillus rhamnosus R0011 | Improved Intestinal Barrier Function | Beneficial | Moderate |
Lactobacillus rhamnosus R0011 | Reduced Dysbiosis | Beneficial | Moderate |
Lactobacillus rhamnosus R0011 | Unchanged Stool Consistency | Neutral | Small |
Lactobacillus rhamnosus R0343ND | Attenuated Enterocyte Injury | Beneficial | Moderate |
Lactobacillus rhamnosus R0343ND | Reduced Intestinal Permeability Defect | Beneficial | Moderate |